Thu, Aug 21, 2014, 8:42 AM EDT - U.S. Markets open in 48 mins.


% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • bioimmunomabman bioimmunomabman Jun 6, 2013 8:55 AM Flag

    Kai, get a real job!

    And I don't suggest biotech analyst as your starting role. Technically, TSRX is not weak, so you have no technical argument. A stock is worth the present value of future earnings and dividends discounted for risk, I am sure they taught you that at the Ross School. You don't have any clue about the earnings potential for TSRX.

    Biotech execs almost never buy stock, they sell their low-priced options and print more free ones and shareholders continue to allow this to happen. Example: ACAD insiders sold some stock in the $8's. I used logic similar to that in your article and sold some $9 calls for about .35. I bought them back for about $3-4 and sold some higher strike, longer dated calls to help absorb the loss and extend out my large cap gain. You can't uses a simple model, or screen for biotech.

13.630.00(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.